definitively rule this out, because it would have implications for treatment and genetic counseling. Because blood could not be used in this instance as a source of germline DNA, we performed Sanger sequencing using DNA extracted from a buccal swab
Search Results
A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation
Justin Lee, Jennifer Axilbund, W. Brian Dalton, Daniel Laheru, Stanley Watkins, David Chu, Karen Cravero, Berry Button, Kelly Kyker-Snowman, Ian Waters, Christopher D. Gocke, Josh Lauring, and Ben Ho Park
Meeting Patients Where They Are: Policy Platform for Telehealth and Cancer Care Delivery
Sheetal Kircher, Nicole Braccio, Kathleen Gallagher, Ruth Carlos, Lynne Wagner, Mary Lou Smith, Alan Balch, and Al B. Benson III
cancer care continuum, including navigation, chemotherapy toxicity management, genetic counseling, clinical trial enrollment, mental health services, survivorship care, and palliative care ( Figure 1 ). 6 – 8 Guidelines need to evolve to offer evidence
New Therapies for Ovarian Cancer
Deborah K. Armstrong
genetic counseling with “strong consideration” for genetic testing, she said. Due to their efficacy in ovarian cancer and some other malignancies, the use of PARP inhibitors has steadily grown since 2014, when olaparib was approved. At the time of Dr
Barriers to Clinical Trial Participation as Perceived by Oncologists and Patients
Neal J. Meropol, Joanne S. Buzaglo, Jennifer Millard, Nevena Damjanov, Suzanne M. Miller, Caroline Ridgway, Eric A. Ross, John D. Sprandio, and Perry Watts
Fleisher L Roussi P . Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service . J Health Commun 2005 ; 10 ( Suppl ): S119 – 136 . 21. Ellis PM . Attitudes
New Therapies for Ovarian Cancer
David M. O’Malley
treatment should not be delayed for genetic counseling. For patients with recurrent or refractory disease, validated molecular testing should be performed in a CLIA-approved facility using the most recently obtained tissue. Testing for patients with
Cancer Risk Reduction Strategies for Transgender, Non-Binary, and Gender-Diverse People With Hereditary Cancer Syndromes
Presented by: Julie S. Mak and Diego Rodriguez
. Mak. “They are often done in different clinics by different providers without a lot of collaboration.” Between 5% and 10% of people with cancer have an inherited pathogenic variant linked to cancer risk. 7 Thus, genetic counseling considerations for
Abstracts From the NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™
chemoprevention but opted out. Of the 306 patients, 48% (n=131) were eligible for genetic counseling, 27 genetic counseling appointments were scheduled but only 19 were kept, and genetic testing was conducted on 8% of patients (n=11), 7 of whom had negative
NCCN News
legislation that would remedy a longstanding Medicare gap, ensuring that beneficiaries at increased risk of cancer have access to standard-of-care genetic counseling, testing, screening, and risk-reducing interventions. This proposed law will enable coverage
When and How to Perform Genetic Testing for Inherited Colorectal Cancer Syndromes
Patrick M. Lynch
the Bayesian principles of Mendelian genetics involved in this process are straightforward, providing formal genetic counseling is nevertheless advisable in most instances, lest missteps in the testing process occur. 10 , 11 As suggested earlier, the
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H. Shah, Whitney S. Goldner, Al B. Benson III, Emily Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, Jennifer Chan, Satya Das, Paxton V. Dickson, Paul Fanta, Thomas Giordano, Thorvardur R. Halfdanarson, Daniel Halperin, Jin He, Anthony Heaney, Martin J. Heslin, Fouad Kandeel, Arash Kardan, Sajid A. Khan, Boris W. Kuvshinoff II, Christopher Lieu, Kimberly Miller, Venu G. Pillarisetty, Diane Reidy, Sarimar Agosto Salgado, Shagufta Shaheen, Heloisa P. Soares, Michael C. Soulen, Jonathan R. Strosberg, Craig R. Sussman, Nikolaos A. Trikalinos, Nataliya A. Uboha, Namrata Vijayvergia, Terence Wong, Beth Lynn, and Cindy Hochstetler
Counseling In the 2021 guidelines, the panel included a new principles of genetic risk assessment and counseling for hereditary endocrine neoplasias. This section outlines how to go about genetic counseling, provides an overview of clinical manifestations